The invention relates to chemical compounds of formula (IB): or a salt thereof. In some embodiments, the invention relates to inhibitors of UDP-3-0 — (R-S-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC). In still further embodiments, the invention relates to pharmaceutical compositions comprising compounds disclosed herein and their use in the prevention and/or treatment of Gram- negative bacterial infections.
该发明涉及
化学式(IB)的化合物或其盐。在某些实施例中,该发明涉及
UDP-3-0-(R-S-羟基肉豆
蔻酰)-
N-乙酰
葡萄糖胺
脱乙酰酶(LpxC)的
抑制剂。在更进一步的实施例中,该发明涉及包含本文披露的化合物的药物组合物及其在预防和/或治疗革兰氏阴性细菌感染中的用途。